Hyperlipidemia Drugs Market
According to Intent Market Research, the Hyperlipidemia Drugs Market is expected to grow from USD 21.4 Billion in 2024-e at a CAGR of 3.3% to touch USD 26.0 Billion by 2030. The Hyperlipidemia Drugs Market is dominated by key players such as Pfizer Inc., Merck & Co., Inc., Sanofi S.A., Amgen Inc., Novartis International AG, AstraZeneca PLC